Objective: Recently, natural exogenous surfactant replacement has been used in experimental models and clinical trials for the treatment of severe respiratory syncytial virus (RSV) disease.

A worldwide scramble began for a way to infuse premature infants with a surfactant that would work in the alveoli. Some labs ...

Pulmonary Alveolar Proteinosis, a rare and chronic lung condition characterized by the accumulation of surfactant within the alveoli, poses significant diagnostic and treatment challenges.